Medtronic Vanta/Seqenita LT Neurostimulation Programmer Software Anomalies Recalled
Medtronic recalls the Vanta/Seqenita LT Clinician Programmer Application due to software anomalies generating error messages that may affect device operation. The recall affects 22 units distributed worldwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a medical device programmer application. Software anomalies may interfere with proper operation of neurostimulation systems, creating a risk of harm to patient care. No reported injuries or illnesses are mentioned in the source.
Plain-English summary
Medtronic Neuromodulation is recalling the Vanta/Seqenita LT Clinician Programmer Application (Model CT900E), a software application used to program neurostimulation systems for pain management. The recall affects 22 units that were distributed worldwide.
The product has been recalled due to software anomalies that generate error messages including 'Too Many Device Found,' 'Unexpected Device Error Code 1502,' and 'System Update Needed, Service Code 303.' These error messages may interfere with normal operation of the clinician programmer.
Affected lot numbers are: NPL3022869, NPL3022873, NPL3022049, NPL3022050, NPL3022795, NPL3022817, NPL3022190, NPL3022191, NPL3022052, NPL3022187, NPL3022193, NPL3022194, NPL3022195, NPL3022212, NPL3022213, NPL3022289, NPL3021964, NPL3022043, NPL3022044, NPL3022034, NPL3021984, NPL3021990 (GTIN 00763000447090).
Clinicians and healthcare facilities using the affected units should contact Medtronic Neuromodulation for instructions on remediation or device replacement.
The recalled product
- Product
- Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain therapy, Model Number CT900E
- Manufacturer
- Medtronic Neuromodulation
- Affected units
- 22
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- GTIN 00763000447090: Serial/Lot Numbers: NPL3022869
- NPL3022873
- NPL3022049
- NPL3022050
- NPL3022795
- NPL3022817
- NPL3022190
- NPL3022191
- NPL3022052
- NPL3022187
- NPL3022193
- NPL3022194
- NPL3022195
- NPL3022212
- NPL3022213
- NPL3022289
- NPL3021964
- NPL3022043
- NPL3022044
- NPL3022034
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 5 recalled by Medtronic Neuromodulation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Medtronic Neuromodulation
See all →- ModerateMedtronic 1x4 pocket adaptor kits carry incorrect use-by dates
FDA (Devices) · 2026-06-03
- ModerateMedtronic 2x4 pocket adaptor kits carry incorrect use-by dates
FDA (Devices) · 2026-06-03
- HighMedtronic SynchroMed Flex Infusion Programmer Software Application
FDA (Devices) · 2026-05-20
- ModerateNeurostimulator clinician programmer app recalled over faults during device use
FDA (Devices) · 2026-01-21
- HighFemoral nails, 360 mm left trochanteric, recalled over undersized shaft diameter
FDA (Devices) · 2025-12-31
Same hazard · software error
See all →- HighQuantum Rehab R-TRAK Powered Wheelchair Controller Recalled Due to Software Issue
FDA (Devices) · 2026-08-12
- HighDASH Rapid PCR Instrument Recalled Due to Software Issue Causing False Co-infection Results
FDA (Devices) · 2026-08-12
- HighQuantum Outback Powered Wheelchair Controller Recalled Due to Unexpected Braking Risk
FDA (Devices) · 2026-08-12
- HighREMISOL Advance Software Version 2.5 Recalled for Incorrect Test Result Reporting
FDA (Devices) · 2026-08-12
- HighQuantum Rehab Q6 Edge 3 Powered Wheelchair Controller Recalled for Unexpected Braking
FDA (Devices) · 2026-08-12